Log In
BCIQ
Print this Print this
 

Basen, voglibose (AO-128)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionAlpha glucosidase inhibitor
Molecular Target Acid alpha glucosidase (GAA)
Mechanism of ActionAlpha glucosidase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsPrevent onset of Type II diabetes in patients with impaired glucose tolerance
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today